Changes in attitudes toward the HPV vaccine in Kenya
5 affiliations
- 1Department of Public Health Policy and Management, New York University School of Global Public Health, New York, New York, United States of America.
- 2Daniel J. Epstein Department of Industrial and Systems Engineering, University of Southern California Viterbi School of Engineering, Los Angeles, California, United States of America.
- 3Innovations for Poverty Action, Sandalwood Lane, Nairobi, Kenya.
- 4Department of Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States of America.
- 5Department of Pediatrics, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States of America.
Abstract
Globally, attitudes about vaccines and vaccination are changing rapidly, but few studies have examined within-person shifts over time. We use a longitudinal survey in Kenya to assess how respondents’ attitudes about the human papillomavirus (HPV) vaccine changed between 2022 and 2024. In 2022, we conducted a random digit-dialed phone survey of 1405 Kenyan parents/caregivers of girls age-eligible for the HPV vaccine; respondents were re-contacted in 2024, and 1093 people (78%) were successfully re-surveyed. Each survey included identical questions about HPV vaccine and vaccination attitudes (adapted from the Vaccine Hesitancy Scale-HPV). We estimate direction and degree of each person’s change in attitude, overall and by construct/question, and explore associations between these changes and respondent demographics, and baseline knowledge about HPV and HPV vaccination. Attitudes about the HPV vaccine changed substantially from 2022 to 2024. Although perceptions of the vaccine’s importance and effectiveness were relatively stable (only 25% of respondents reported any attitude change), there were significantly more changes among respondents with lower educational attainment and who were unemployed. Safety perceptions changed substantially over this period: two-thirds of respondents changed their beliefs around the vaccine’s side effects and riskiness. Approximately one-quarter of respondents developed a worse safety attitudes, while 18.9% of respondents improved their safety attitude. Among individuals with lower socioeconomic status, attitudes about following a clinician’s HPV vaccination recommendation and riskiness of the HPV vaccine significantly worsened over this period. We found that, in this population of Kenyan adults and over a two-year period, attitudes about the HPV vaccine have changed both positively and negatively. Targeted interventions may be needed, particularly with less socioeconomically-advantaged groups, to reinforce messages about the vaccine’s importance, effectiveness, and safety. Further research is needed about reasons for the large changes in safety perceptions, both toward more and less favorable views.
Related
- Strengthening post-market COVID-19 vaccine safety surveillance and research: An interpretive description study from Kenya, South Africa, and Canada
- Which changes in adolescents' knowledge, attitudes, and practices following a school-based intervention in France increase HPV vaccination uptake and intentions? A mediation analysis
- Smallholder farmers' preferences for public expenditure priorities to support maize productivity: evidence from a best–worst scaling experiment in western Kenya
- Seasonal Dietary Composition of the Mountain Bongo ( Tragelaphus eurycerus ssp. isaaci ) at the Mount Kenya Wildlife Conservancy
- Retrospective Serological Survey of Equine Influenza Virus and Piroplasm Parasites in Free-Ranging Wild Equids from Kenya and Tanzania.
BibTeX
@article{moucheraud2026changes,
title = {{Changes in attitudes toward the HPV vaccine in Kenya}},
author = {Corrina Moucheraud and Jinghong Miao and Eric Ochieng and Suyanpeng Zhang and George Ganda and Ginger Golub and Risa M Hoffman and Peter G Szilagyi and Sze-Chuan Suen},
journal = {PLOS Global Public Health},
year = {2026},
month = oct,
doi = {10.1371/journal.pgph.0007508},
url = {https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0007508},
note = {CC BY},
}
RIS
TY - JOUR
TI - Changes in attitudes toward the HPV vaccine in Kenya
AU - Corrina Moucheraud
AU - Jinghong Miao
AU - Eric Ochieng
AU - Suyanpeng Zhang
AU - George Ganda
AU - Ginger Golub
AU - Risa M Hoffman
AU - Peter G Szilagyi
AU - Sze-Chuan Suen
PY - 2026
DA - 2026/10/23
JO - PLOS Global Public Health
DO - 10.1371/journal.pgph.0007508
UR - https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0007508
AB - Globally, attitudes about vaccines and vaccination are changing rapidly, but few studies have examined within-person shifts over time. We use a longitudinal survey in Kenya to assess how respondents’ attitudes about the human papillomavirus (HPV) vaccine changed between 2022 and 2024. In 2022, we conducted a random digit-dialed phone survey of 1405 Kenyan parents/caregivers of girls age-eligible for the HPV vaccine; respondents were re-contacted in 2024, and 1093 people (78%) were successfully re-surveyed. Each survey included identical questions about HPV vaccine and vaccination attitudes (adapted from the Vaccine Hesitancy Scale-HPV). We estimate direction and degree of each person’s change in attitude, overall and by construct/question, and explore associations between these changes and respondent demographics, and baseline knowledge about HPV and HPV vaccination. Attitudes about the HPV vaccine changed substantially from 2022 to 2024. Although perceptions of the vaccine’s importance and effectiveness were relatively stable (only 25% of respondents reported any attitude change), there were significantly more changes among respondents with lower educational attainment and who were unemployed. Safety perceptions changed substantially over this period: two-thirds of respondents changed their beliefs around the vaccine’s side effects and riskiness. Approximately one-quarter of respondents developed a worse safety attitudes, while 18.9% of respondents improved their safety attitude. Among individuals with lower socioeconomic status, attitudes about following a clinician’s HPV vaccination recommendation and riskiness of the HPV vaccine significantly worsened over this period. We found that, in this population of Kenyan adults and over a two-year period, attitudes about the HPV vaccine have changed both positively and negatively. Targeted interventions may be needed, particularly with less socioeconomically-advantaged groups, to reinforce messages about the vaccine’s importance, effectiveness, and safety. Further research is needed about reasons for the large changes in safety perceptions, both toward more and less favorable views.
SN - 2767-3375
ER -